Sun, Si-Jia
Ai, Ying-Jie
Duan, Kun-Long
Zhang, Jin-Ye
Zhang, Cheng
Sun, Yi-Ping
Xiong, Yue
Guan, Kun-Liang
Yuan, Hai-Xin http://orcid.org/0000-0002-1624-3934
Funding for this research was provided by:
National Natural Science Foundation of China (82172595)
National Key Research and Development Project of China Development Fund for Shanghai Talents Supporting Fund for Innovation and Entrepreneurship by Chongqing Returned Oversea Scholars
Article History
Received: 25 May 2022
Revised: 21 October 2022
Accepted: 26 October 2022
First Online: 8 November 2022
Competing interests
: KLG is a co-founder of Vivace Therapeutics. YX is a co-founder of Cullgen Inc. Other authors declare no competing financial interests.